EUVIMEDEUVIMED entdecken
Crossref

Association Between Time‐In‐Therapeutic Range of Calcineurin Inhibitor Trough Level and Short‐Term Outcomes of Recipients After Adult Living‐Donor Liver Transplantation

Ryugen Takahashi, Nobuhisa Akamatsu iD, Yuya Saruta, Mei Nakamura, Yujiro Nishioka, Yuichiro Mihara, Akihiko Ichida, Takeshi Takamoto, Yoshikuni Kawaguchi, Kiyoshi Hasegawa iD

Journal of Hepato-Biliary-Pancreatic Sciences · 2025

DOI: 10.1002/jhbp.70046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2025. Verfasst von Ryugen Takahashi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Jap…. Hauptthemen laut MEDLINE: Liver Transplantation, Calcineurin Inhibitors, Living Donors, Graft Rejection. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Time‐in therapeutic range (TTR) is defined as the time a drug concentration remains within the therapeutic range. To explore the optimal management of calcineurin inhibitor (CNI), we investigated how TTR percentage (TTR%) in two different CNI protocols relates to short‐term outcomes after living‐donor liver transplantation (LDLT).

Methods

TTR% was estimated for two different protocols in 352 adult LDLT recipients over 90 days in this retrospective, single‐center study. Short‐term outcomes were compared among the TTR% groups in each protocol.

Results

Higher TTR% was associated with better acute rejection‐free survival: 96.2%, 86.1%, 74.7%, and 38.9% for TTR% ≥ 60%, ≥ 50%–< 60%, ≥ 40%–< 50%, and < 40%, in the low‐target protocol, respectively ( p < 0.001, log‐rank test); 73.7%, 74.3%, 63.6%, and 48.3%, in the high‐target protocol, respectively ( p = 0.003). The incidence of adverse events was similar among TTR% groups in each protocol. Multivariate analysis revealed higher TTR% was protective for rejection‐free survival, and this trend was particularly pronounced in the low‐target protocol.

Conclusions

High TTR%, reflecting well‐controlled CNI levels, was associated with better outcomes after LDLT. The outcome of high TTR% in low‐target protocol seems better, but further prospective validation is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCalcineurin InhibitorsLiving DonorsGraft RejectionImmunosuppressive AgentsHumansMaleFemaleRetrospective StudiesMiddle AgedAdultTreatment OutcomeTime FactorsGraft Survival

Stichwörter der Autor:innen

acute rejectioncalcineurin inhibitorsliving donor liver transplantationtime‐in‐therapeutic range

Substanzen

Calcineurin InhibitorsImmunosuppressive Agents

Autor:innen und Institutionen

  • Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.

ORCID-Profile: Nobuhisa Akamatsu, Kiyoshi Hasegawa

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Takahashi, R., Akamatsu, N., Saruta, Y., Nakamura, M., Nishioka, Y., Mihara, Y., Ichida, A., Takamoto, T., Kawaguchi, Y., & Hasegawa, K. (2025). Association Between Time‐In‐Therapeutic Range of Calcineurin Inhibitor Trough Level and Short‐Term Outcomes of Recipients After Adult Living‐Donor Liver Transplantation. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70046

Vancouver

Takahashi R, Akamatsu N, Saruta Y, Nakamura M, Nishioka Y, Mihara Y, et al. Association Between Time‐In‐Therapeutic Range of Calcineurin Inhibitor Trough Level and Short‐Term Outcomes of Recipients After Adult Living‐Donor Liver Transplantation. Journal of Hepato-Biliary-Pancreatic Sciences. 2025. doi:10.1002/jhbp.70046

BibTeX
@article{Takahashi2025,
  author = {Takahashi, Ryugen and Akamatsu, Nobuhisa and Saruta, Yuya and Nakamura, Mei and Nishioka, Yujiro and Mihara, Yuichiro and Ichida, Akihiko and Takamoto, Takeshi and Kawaguchi, Yoshikuni and Hasegawa, Kiyoshi},
  title = {Association Between Time‐In‐Therapeutic Range of Calcineurin Inhibitor Trough Level and Short‐Term Outcomes of Recipients After Adult Living‐Donor Liver Transplantation},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2025},
  doi = {10.1002/jhbp.70046}
}
Kostenlos starten →